Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alpha-lipoic acid is a naturally occurring fatty acid and antioxidant that plays a role in mitochondrial energy metabolism. It acts as a cofactor for mitochondrial enzyme complexes and helps regenerate other antioxidants such as vitamin C and glutathione. As an antioxidant supplement (nutraceutical), it has been studied for use in diabetic neuropathy (nerve pain), weight loss support in diabetes or obesity management programs; wound healing; lowering blood sugar; improving skin discoloration from vitiligo; reducing complications after coronary artery bypass graft surgery; and potentially slowing cognitive decline in dementia. However its efficacy for many of these uses remains unproven or only modestly supported by clinical evidence. It is not FDA-approved as a pharmaceutical drug but is widely available as an over-the-counter dietary supplement[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpha-lipoic acid.